Back to search

Article

Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2

2026-03-28

Abstract excerpt

In the Global Parkinson’s Genetics Program (GP2) we aim to advance precision medicine by integrating large-scale clinico-genetic data from diverse populations worldwide. We investigated potentially trial-eligible carriers of pathogenic and high-risk GBA1 and LRRK2 variants and conducted a global precision-medicine survey across GP2 sites. Among 65,509 individuals with Parkinson’s disease, we identified 9,019 (13...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e96991d0-e7d4-5195-a9e1-e089b220936f
DOI
10.64898/2026.03.26.26349418
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2DOI 10.64898/2026.03.26.26349418
Select a neighboring publication to make it the new centre.